Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Allen

Showing results (181-190 of 202) with videos related to

Pageof 21
Sort By:
MMWR. Morbidity and Mortality Weekly Report|February 22, 2024
Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018-2024Chris Edens, Benjamin R Clopper, Jourdan DeVies, et al.
Plos Neglected Tropical Diseases|May 28, 2024
Novel paradigm enables accurate monthly gestational screening to prevent congenital toxoplasmosis and moreYing Zhou, Karen Leahy, Andrew Grose, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2015
Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013Daniel C Payne, Rangaraj Selvarangan, Parvin H Azimi, et al.
PLOS Global Public Health|September 20, 2024
Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trialVimla Naicker, Fatima Laher, Linda-Gail Bekker, et al.
JAMA Network Open|July 19, 2023
Neurological and Psychological Sequelae Associated With Multisystem Inflammatory Syndrome in ChildrenCaitlin K Rollins, Johanna Calderon, David Wypij, et al.
Open Forum Infectious Diseases|November 28, 2025
Adenovirus Types in US Children Hospitalized or Seen in the Emergency Department With Acute Respiratory Illness, 2016-2019Tess Stopczynski, Varvara Probst, Adam Gailani, et al.
Plos Medicine|May 23, 2020
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trialsZoe Moodie, Stephen R Walsh, Fatima Laher, et al.
Journal of the Pediatric Infectious Diseases Society|May 31, 2025
Adenovirus Species in U.S. Children With Acute Respiratory Illness, 2016-2019Varvara Probst, Tess Stopczynski, Justin Z Amarin, et al.
MMWR. Morbidity and Mortality Weekly Report|March 8, 2024
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024Heidi L Moline, Ayzsa Tannis, Ariana P Toepfer, et al.
Eclinicalmedicine|November 8, 2023
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country studyGustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
Pageof 21

Showing results (181-190 of 202) with videos related to

Sort By:
Pageof 21
MMWR. Morbidity and Mortality Weekly Report|February 22, 2024
Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018-2024Chris Edens, Benjamin R Clopper, Jourdan DeVies, et al.
Plos Neglected Tropical Diseases|May 28, 2024
Novel paradigm enables accurate monthly gestational screening to prevent congenital toxoplasmosis and moreYing Zhou, Karen Leahy, Andrew Grose, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2015
Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013Daniel C Payne, Rangaraj Selvarangan, Parvin H Azimi, et al.
PLOS Global Public Health|September 20, 2024
Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1-2 randomized double-blind placebo-controlled trialVimla Naicker, Fatima Laher, Linda-Gail Bekker, et al.
JAMA Network Open|July 19, 2023
Neurological and Psychological Sequelae Associated With Multisystem Inflammatory Syndrome in ChildrenCaitlin K Rollins, Johanna Calderon, David Wypij, et al.
Open Forum Infectious Diseases|November 28, 2025
Adenovirus Types in US Children Hospitalized or Seen in the Emergency Department With Acute Respiratory Illness, 2016-2019Tess Stopczynski, Varvara Probst, Adam Gailani, et al.
Plos Medicine|May 23, 2020
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trialsZoe Moodie, Stephen R Walsh, Fatima Laher, et al.
Journal of the Pediatric Infectious Diseases Society|May 31, 2025
Adenovirus Species in U.S. Children With Acute Respiratory Illness, 2016-2019Varvara Probst, Tess Stopczynski, Justin Z Amarin, et al.
MMWR. Morbidity and Mortality Weekly Report|March 8, 2024
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024Heidi L Moline, Ayzsa Tannis, Ariana P Toepfer, et al.
Eclinicalmedicine|November 8, 2023
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country studyGustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
Pageof 21